allantoin has been researched along with Inflammation in 12 studies
Inflammation: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to evaluate and compare the postoperative effect of a topic gel containing chlorhexidine, chitosan, allantoine and dexpanthenol versus a placebo for pain and inflammation control after third molar surgery." | 9.34 | Efficacy of a topical gel containing chitosan, chlorhexidine, allantoin and dexpanthenol for pain and inflammation control after third molar surgery: A randomized and placebo-controlled clinical trial. ( Bornstein, MM; González-Serrano, J; López-Quiles, J; Molinero-Mourelle, P; Rubio-Alonso, L; Sáez-Alcaide, LM, 2020) |
| " After ET administration, some decreasing trends were seen in biomarkers of oxidative damage and inflammation, including allantoin (urate oxidation), 8-hydroxy-2'-deoxyguanosine (DNA damage), 8-iso-PGF2α (lipid peroxidation), protein carbonylation, and C-reactive protein." | 7.85 | Administration of Pure Ergothioneine to Healthy Human Subjects: Uptake, Metabolism, and Effects on Biomarkers of Oxidative Damage and Inflammation. ( Cheah, IK; Halliwell, B; Lim, KH; Tang, RM; Yew, TS, 2017) |
| "24; p < 0." | 6.80 | Efficacy of chlorhexidine, dexpanthenol, allantoin and chitosan gel in comparison with bicarbonate oral rinse in controlling post-interventional inflammation, pain and cicatrization in subjects undergoing dental surgery. ( Estrugo-Devesa, A; González-Navarro, B; Jan-Pallí, E; Jané-Salas, E; lez-Navarro, BG; Lope-Lopez, J; Lopez-Lopez, J; Milani, M, 2015) |
| "The aim of this study was to evaluate and compare the postoperative effect of a topic gel containing chlorhexidine, chitosan, allantoine and dexpanthenol versus a placebo for pain and inflammation control after third molar surgery." | 5.34 | Efficacy of a topical gel containing chitosan, chlorhexidine, allantoin and dexpanthenol for pain and inflammation control after third molar surgery: A randomized and placebo-controlled clinical trial. ( Bornstein, MM; González-Serrano, J; López-Quiles, J; Molinero-Mourelle, P; Rubio-Alonso, L; Sáez-Alcaide, LM, 2020) |
| "Amelioration of both oxidative and inflammation status after cholesterol lowering treatment in CKD might be mediated by restoration of antioxidant taurine concentrations during therapy (from 51." | 5.20 | Impact of cholesterol lowering treatment on plasma kynurenine and tryptophan concentrations in chronic kidney disease: relationship with oxidative stress improvement. ( Carru, C; Mangoni, AA; Sanna, M; Satta, AE; Sotgia, S; Zinellu, A, 2015) |
| " After ET administration, some decreasing trends were seen in biomarkers of oxidative damage and inflammation, including allantoin (urate oxidation), 8-hydroxy-2'-deoxyguanosine (DNA damage), 8-iso-PGF2α (lipid peroxidation), protein carbonylation, and C-reactive protein." | 3.85 | Administration of Pure Ergothioneine to Healthy Human Subjects: Uptake, Metabolism, and Effects on Biomarkers of Oxidative Damage and Inflammation. ( Cheah, IK; Halliwell, B; Lim, KH; Tang, RM; Yew, TS, 2017) |
| " Plasma MED concentrations, inflammation and oxidative stress indices [Kynurenine/Tryptophan (Kyn/Trp) ratio, malondialdehyde (MDA) and allantoin/uric acid (All/UA) ratio] were measured in 30 CKD patients randomized to three cholesterol lowering regimens for 12 months (simvastatin 40mg/day, ezetimibe/simvastatin 10/20mg/day, or ezetimibe/simvastatin 10/40mg/day)." | 3.83 | Effect of cholesterol lowering treatment on plasma markers of endothelial dysfunction in chronic kidney disease. ( Carru, C; Ena, S; Mangoni, AA; Satta, AE; Sotgia, S; Sotgiu, E; Zinellu, A, 2016) |
| "24; p < 0." | 2.80 | Efficacy of chlorhexidine, dexpanthenol, allantoin and chitosan gel in comparison with bicarbonate oral rinse in controlling post-interventional inflammation, pain and cicatrization in subjects undergoing dental surgery. ( Estrugo-Devesa, A; González-Navarro, B; Jan-Pallí, E; Jané-Salas, E; lez-Navarro, BG; Lope-Lopez, J; Lopez-Lopez, J; Milani, M, 2015) |
| "Comfrey has a centuries-old tradition as a medicinal plant." | 2.48 | Comfrey: a clinical overview. ( Staiger, C, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 9 (75.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Saunders, MJ | 1 |
| Edwards, BS | 1 |
| Zhu, J | 1 |
| Sklar, LA | 1 |
| Graves, SW | 1 |
| Sáez-Alcaide, LM | 1 |
| Molinero-Mourelle, P | 1 |
| González-Serrano, J | 1 |
| Rubio-Alonso, L | 1 |
| Bornstein, MM | 1 |
| López-Quiles, J | 1 |
| Dickerhof, N | 1 |
| Pearson, JF | 1 |
| Hoskin, TS | 1 |
| Berry, LJ | 1 |
| Turner, R | 2 |
| Sly, PD | 1 |
| Kettle, AJ | 2 |
| Zinellu, A | 2 |
| Sotgia, S | 2 |
| Mangoni, AA | 2 |
| Sanna, M | 1 |
| Satta, AE | 2 |
| Carru, C | 2 |
| Lopez-Lopez, J | 1 |
| Lope-Lopez, J | 1 |
| Jan-Pallí, E | 1 |
| lez-Navarro, BG | 1 |
| González-Navarro, B | 1 |
| Jané-Salas, E | 1 |
| Estrugo-Devesa, A | 1 |
| Milani, M | 1 |
| Sotgiu, E | 1 |
| Ena, S | 1 |
| Cheah, IK | 1 |
| Tang, RM | 1 |
| Yew, TS | 1 |
| Lim, KH | 1 |
| Halliwell, B | 1 |
| Meotti, FC | 1 |
| Jameson, GN | 1 |
| Harwood, DT | 1 |
| Stockwell, S | 1 |
| Rees, MD | 1 |
| Thomas, SR | 1 |
| Staiger, C | 1 |
| Araújo, LU | 1 |
| Reis, PG | 1 |
| Barbosa, LC | 1 |
| Saúde-Guimarães, DA | 1 |
| Grabe-Guimarães, A | 1 |
| Mosqueira, VC | 1 |
| Carneiro, CM | 1 |
| Silva-Barcellos, NM | 1 |
| Becker, BF | 1 |
| Kastenbauer, S | 1 |
| Ködel, U | 1 |
| Kiesl, D | 1 |
| Pfister, HW | 1 |
| Jonas, FJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Investigating the Efficacy of Ergothioneine to Delay Cognitive Decline in Mild Cognitively Impaired Subjects[NCT03641404] | Phase 3 | 106 participants (Anticipated) | Interventional | 2018-08-31 | Not yet recruiting | ||
| The Effects of Daily Anti-inflammatory Supplementation on Foundation Pain Index Scores in Chronic Opiate Patients[NCT05896878] | 20 participants (Anticipated) | Interventional | 2023-07-10 | Enrolling by invitation | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for allantoin and Inflammation
| Article | Year |
|---|---|
Comfrey: a clinical overview.
Topics: Allantoin; Analgesics; Anti-Inflammatory Agents; Cinnamates; Comfrey; Depsides; Humans; Inflammation | 2012 |
3 trials available for allantoin and Inflammation
8 other studies available for allantoin and Inflammation
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Pr | 2010 |
Oxidative stress in early cystic fibrosis lung disease is exacerbated by airway glutathione deficiency.
Topics: Age of Onset; Allantoin; Bronchiectasis; Bronchoalveolar Lavage Fluid; Case-Control Studies; Child; | 2017 |
Effect of cholesterol lowering treatment on plasma markers of endothelial dysfunction in chronic kidney disease.
Topics: Allantoin; Anticholesteremic Agents; Arginine; Biomarkers; Cholesterol; Endothelium; Ezetimibe; Fema | 2016 |
Administration of Pure Ergothioneine to Healthy Human Subjects: Uptake, Metabolism, and Effects on Biomarkers of Oxidative Damage and Inflammation.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Allantoin; Antioxidants; Betaine; Biomarkers; C-Reactive Protein; Deoxy | 2017 |
Administration of Pure Ergothioneine to Healthy Human Subjects: Uptake, Metabolism, and Effects on Biomarkers of Oxidative Damage and Inflammation.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Allantoin; Antioxidants; Betaine; Biomarkers; C-Reactive Protein; Deoxy | 2017 |
Administration of Pure Ergothioneine to Healthy Human Subjects: Uptake, Metabolism, and Effects on Biomarkers of Oxidative Damage and Inflammation.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Allantoin; Antioxidants; Betaine; Biomarkers; C-Reactive Protein; Deoxy | 2017 |
Administration of Pure Ergothioneine to Healthy Human Subjects: Uptake, Metabolism, and Effects on Biomarkers of Oxidative Damage and Inflammation.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Allantoin; Antioxidants; Betaine; Biomarkers; C-Reactive Protein; Deoxy | 2017 |
Urate as a physiological substrate for myeloperoxidase: implications for hyperuricemia and inflammation.
Topics: Allantoin; Cardiovascular Diseases; Humans; Hydrogen Peroxide; Hyperuricemia; Inflammation; NADPH Ox | 2011 |
In vivo wound healing effects of Symphytum officinale L. leaves extract in different topical formulations.
Topics: Administration, Topical; Allantoin; Animals; Chemistry, Pharmaceutical; Comfrey; Emulsions; Female; | 2012 |
Urate oxidation in CSF and blood of patients with inflammatory disorders of the nervous system.
Topics: Allantoin; Blood-Brain Barrier; Brain; Central Nervous System Diseases; Guillain-Barre Syndrome; Hum | 2004 |
[Experiences on the use of medicinal plant extracts for traumatic and inflammatory swelling of the soft tissue].
Topics: Allantoin; Choline; Humans; Hydantoins; Inflammation; Plants, Medicinal; Wounds and Injuries | 1966 |